ReviewClinical rheumatology2012
The initial presentation of systemic lupus erythematosis with aplastic anemia successfully treated with rituximab.
Review in Clinical rheumatology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 17 citations in OpenAlex.
- Case Report: Rare aplastic anemia in pediatric systemic lupus erythematosus: a case series and systematic literature review.Frontiers in pediatrics · 2025Article
- Dramatic Response of Lupus Enteritis, Nephritis, and Pancytopenia to Plasmapheresis and Rituximab.Case reports in gastrointestinal medicine · 2022Article
- Lessons learned from bone marrow failure in systemic lupus erythematosus: Case reports and review of the literature.Seminars in arthritis and rheumatism · 2018Review
- Aplastic anemia as a feature of systemic lupus erythematosus: a case report and literature review.Rheumatology international · 2015Review
- Systemic lupus erythematosis with severe aplastic anemia successfully treated with rituximab and antithymocyte globulin.Pakistan journal of medical sciences · 2014Article
- Severe aplastic anemia associated with eosinophilic fasciitis: report of 4 cases and review of the literature.Medicine · 2013Review
- Aplastic anemia associated to systemic lupus erythematosus in an AIDS patient: a case report.Revista brasileira de hematologia e hemoterapia · 2013Article
- B-cell depletion in SLE: clinical and trial experience with rituximab and ocrelizumab and implications for study design.Arthritis research & therapy · 2013Review
- Bullous Pemphigoid Accompanied by Aplastic Anemia: The Induction of IL-17-Producing Cells in the Affected Areas of the Skin.Case reports in dermatology · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hematologic disorders are common in autoimmune diseases. First presentation of systemic lupus erythematosis with aplastic anemia is extremely rare. We report a patient with the diagnosis of secondary aplastic anemia associated with lupus. All routine medications were not effective. She received Rituximab and her response was satisfactory. Her hematologic parameters were within normal range until last follow-up, six months after therapy was initiated with Rituximab. Review of literature displayed 23 cases of acquired aplastic anemia secondary to systemic lupus erythematosis; however, this is the first time the new drug therapy was used for the treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.